Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Rotrosen

Showing results (31-40 of 157) with videos related to

Pageof 16
Sort By:
Schizophrenia Research|September 27, 2005
Diurnal variation in plasma homovanillic acid in patients with schizophrenia and healthy controlsErica Duncan, Annie M Bollini, Michael Sanfilipo, et al.
Lancet (London, England)|April 23, 2013
Commitment to assessment and treatment: comprehensive care for patients gravely disabled by alcohol use disordersRyan P McCormack, Arthur R Williams, Lewis R Goldfrank, et al.
Psychiatry Research|November 12, 2002
Cognitive performance in schizophrenia: relationship to regional brain volumes and psychiatric symptomsMichael Sanfilipo, Todd Lafargue, Henry Rusinek, et al.
Substance Abuse|January 24, 2012
Buprenorphine-naloxone maintenance following release from jailJoshua D Lee, Ellie Grossman, Andrea Truncali, et al.
Journal of the National Medical Association|February 4, 2011
Substance abuse treatment as HIV prevention: more questions than answersLawrence S Brown, Steven Kritz, Edmund J Bini, et al.
American Journal of Epidemiology|December 22, 2022
Optimally Choosing Medication Type for Patients With Opioid Use DisorderKara E Rudolph, Nicholas T Williams, Iván Díaz, et al.
Psychotherapy Research : Journal of the Society for Psychotherapy Research|January 15, 2015
Predicting outcome of substance abuse treatment in a feedback study: Can recovery curves be improved upon?Paul Crits-Christoph, Hannah M Markell, Robert Gallop, et al.
Addiction (Abingdon, England)|February 24, 2015
Opioid treatment at release from jail using extended-release naltrexone: a pilot proof-of-concept randomized effectiveness trialJoshua D Lee, Ryan McDonald, Ellie Grossman, et al.
Schizophrenia Research|June 5, 2007
Relation of neurological soft signs to psychiatric symptoms in schizophreniaVijay A Mittal, Wendy Hasenkamp, Michael Sanfilipo, et al.
American Journal of Epidemiology|February 1, 2023
Rudolph et al. Respond to "Mathematization of Epidemiology"Kara E Rudolph, Nicholas T Williams, Iván Díaz, et al.
Pageof 16

Showing results (31-40 of 157) with videos related to

Sort By:
Pageof 16
Schizophrenia Research|September 27, 2005
Diurnal variation in plasma homovanillic acid in patients with schizophrenia and healthy controlsErica Duncan, Annie M Bollini, Michael Sanfilipo, et al.
Lancet (London, England)|April 23, 2013
Commitment to assessment and treatment: comprehensive care for patients gravely disabled by alcohol use disordersRyan P McCormack, Arthur R Williams, Lewis R Goldfrank, et al.
Psychiatry Research|November 12, 2002
Cognitive performance in schizophrenia: relationship to regional brain volumes and psychiatric symptomsMichael Sanfilipo, Todd Lafargue, Henry Rusinek, et al.
Substance Abuse|January 24, 2012
Buprenorphine-naloxone maintenance following release from jailJoshua D Lee, Ellie Grossman, Andrea Truncali, et al.
Journal of the National Medical Association|February 4, 2011
Substance abuse treatment as HIV prevention: more questions than answersLawrence S Brown, Steven Kritz, Edmund J Bini, et al.
American Journal of Epidemiology|December 22, 2022
Optimally Choosing Medication Type for Patients With Opioid Use DisorderKara E Rudolph, Nicholas T Williams, Iván Díaz, et al.
Psychotherapy Research : Journal of the Society for Psychotherapy Research|January 15, 2015
Predicting outcome of substance abuse treatment in a feedback study: Can recovery curves be improved upon?Paul Crits-Christoph, Hannah M Markell, Robert Gallop, et al.
Addiction (Abingdon, England)|February 24, 2015
Opioid treatment at release from jail using extended-release naltrexone: a pilot proof-of-concept randomized effectiveness trialJoshua D Lee, Ryan McDonald, Ellie Grossman, et al.
Schizophrenia Research|June 5, 2007
Relation of neurological soft signs to psychiatric symptoms in schizophreniaVijay A Mittal, Wendy Hasenkamp, Michael Sanfilipo, et al.
American Journal of Epidemiology|February 1, 2023
Rudolph et al. Respond to "Mathematization of Epidemiology"Kara E Rudolph, Nicholas T Williams, Iván Díaz, et al.
Pageof 16